15 years of antibiotic stewardship policy in the Nancy Teaching Hospital

Medecine et Maladies Infectieuses

Volumn 41, Issue 10, 2011, Pages 532-539

  Bevilacqua, S ^a   Demore B ^a,d   Boschetti, E ^a   Doco Lecompte, T ^a   May, I ^a   May, T ^a,e   Rabaud, C ^a,e   Thilly, N ^b,c  

^a CHU NANCY BRABOIS   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

^e UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Antibiotic stewardship; DDD

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC STEWARDSHIP POLICY; ARTICLE; DRUG COST; DRUG MONITORING; DRUG QUALITY; DRUG USE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; OPERATIONAL INFECTIOUS DISEASE TEAM; PRACTICE GUIDELINE; PRESCRIPTION; TEACHING HOSPITAL;

ANTI-BACTERIAL AGENTS; DRUG AND NARCOTIC CONTROL; DRUG UTILIZATION; FRANCE; HOSPITALS, TEACHING; HUMANS; TIME FACTORS;

EID: 80054047386     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2011.08.001     Document Type: Article

References (21)

1. Nathwani D., Davey P. Antibiotic prescribing are there lessons for physicians. QJM 1999, 92:287-292.
2. Cars O., Mölstad S., Melander A. Variation in antibiotic use in the European Union. Lancet 2001, 9:1851-1853.
3. Schlemmer B., Dangoumau J., Acar J., et al. Du bon usage des antibiotiques à l'hôpital 1998, Monographie « communication Partenaire Santé », Paris.
4. Harbarth S., Samore M.H. Antimicrobial resistance determinants and future control. Emerg Infect Dis 2005, 11:794-801.
5. Meyer E., Buttler J., Schneider C., Strehl E., Schroeren-Boersch B., Gastmeier P. Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced. J Antimicrob Chemother 2007, 59:1148-1154.
6. Ferech M., Coenen S., Malhotra-Kumar S., et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother 2006, 58:401-407.
7. Goossens H. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother 2006, 58:901-902.
8. Vander Stichele R.H., Elseviers M.M., Ferech M., Blot S., Goossens H. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother 2006, 58:159-167.
9. Goettsch W., Bronzwaer S.L., de Neeling A.J., et al. Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European Antimicrobial Resistance Surveillance System (EARSS). Clin Microbiol Infect 2000, 6:59-63.
10. Mevius D.J., Sprenger M.J., Wegener H.C. EU conference " The Microbial Threat" Int J Antimicrob Agents 1999, 11:101-105.
11. Goossens H., Ferech M., Vander Stichele R. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005, 365:548-549. Elseviers M. for the E.S.A.C. ProjectGroup.
12. Agence Nationale pour l'Accréditation des Etablissements de Santé (ANAES). Le bon usage des antibiotiques à l'hôpital. Recommandations pour maîtriser le développement de la résistance bactérienne 1996, ANDEM, Paris.
13. Ministère en charge de la santé. Circulaire noDHOS/E2/DGS/SD5A/2002/272 du 2 mai 2002 relative au bon usage des antibiotiques dans les établissements de santé et à la mise en place à titre expérimental de centres de conseil en antibiothérapie pour les médecins libéraux.(site consulté en décembre 2009). http://nosobase.chulyon.fr/legislation/antibiotique/ci020502.htm.
14. Miliani K., L'Hériteau F., Alfandari S., et al. Antimicrobial Surveillance Network Specific control measures for antibiotic prescription are related to lower consumption in hospitals: results from a French multicentre pilot study. J Antimicrob Chemother 2008, 62:823-829.
15. Spellberg B., Powers J.H., Brass E.P., Miller L.G., Edwards J.E. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 2004, 38:1279-1286.
16. Byl B., Clevenbergh P., Jacobs F., Struelens M.J., Zech F., Kentos A Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 1999, 29:60-66.
17. Roger P.M., Hyvernat H., Verleine-Pugliese S., Bourroul C., Giordano J., Fosse T. Systematic infection consultation in the intensive care unit. Impact of short-term antibiotic use. Presse Med 2000, 29:1640-1644.
18. WHO collaborating centre for drug statistics methodology. ATC/DDD index. 2005. Available from: URL. http://www.whocc.no/atcddd/.
19. Roberts R.R., Hota B., Ahmad I., et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis 2009, 49:1175-1184.
20. Gyssens I.C., Kullberg B.J., van der Meer J.W. Clinical results and costs due to improved antibiotics policies. Ned Tijdschr Geneeskd 1999, 143:2361-2364.
21. Saizy-Callaert S., Causse R., Furhman C., Le Paih M., Thébault A., Chouaïd C. Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital. J Hosp Infect 2003, 53:177-182.